MedTrace Logo

Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain

NCT06351917 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-12-05

No results posted yet for this study

Summary

This is a randomised, double-blind, placebo controlled, 2 arm parallel clinical trial to evaluate the effect of topical PlexoZome® Levagen® spray on relief of post exercise knee joint pain in healthy adults compared to placebo over 4 weeks duration.

Conditions

  • Knee Joint Pain

Interventions

DRUG

PlexoZome® Levagen® topical spray solution

PlexoZome® Levagen® topical spray solution 10mg/g providing 1.8mg active per pump

DRUG

Placebo topical spray solution

Placebo topical spray solution topical spray solution 0mg/g providing 0mg active per pump

Sponsors & Collaborators

  • RDC Clinical Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Amanda Rao, PhD · RDC Clinical Pty Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-24
Primary Completion
2024-06-18
Completion
2024-06-18

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06351917 on ClinicalTrials.gov